Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women

British Journal of Nutrition

Volumn 109, Issue 12, 2013, Pages 2269-2275

  Aarestrup, Julie ^a   Kyro, Cecilie ^a   Knudsen, Knud E B ^b   Weiderpass, Elisabete ^c,d,e,f   Christensen, Jane ^a   Kristensen, Mette ^g   Würtz, Anne M L ^a   Johnsen, Nina F ^a   Overvad, Kim ^b   Tjonneland, Anne ^a   Olsen, Anja ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF TROMSØ   (Norway)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Case cohort studies; Endometrial cancer; Enterolactone; Phyto oestrogens

Indexed keywords

ANTIBIOTIC AGENT; ENTEROLACTONE;

ADULT; ARTICLE; BODY MASS; CANCER INCIDENCE; CASE STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DANISH; DIET; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ETHNIC GROUP; FEMALE; FLUOROIMMUNOASSAY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MENOPAUSE; PROSPECTIVE STUDY; QUESTIONNAIRE; TIME;

4-BUTYROLACTONE; COHORT STUDIES; DENMARK; DIET SURVEYS; ENDOMETRIAL NEOPLASMS; FEMALE; FLUOROIMMUNOASSAY; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; LIGNANS; MIDDLE AGED; PHYTOESTROGENS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES;

EID: 84878414479     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004424     Document Type: Article

References (25)

1. Globocan 2008 (2008) Cancer Incidence, Mortality and Prevalence Worldwide in 2008. International Agency for Research on Cancer (IARC). World Health Organization (WHO). http://www.iarc.fr (accessed March 2012).
2. Kaaks R, Lukanova A & Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11, 1531-1543. (Pubitemid 36020003)
3. Adlercreutz H (2007) Lignans and human health. Crit Rev Clin Lab Sci 44, 483-525. (Pubitemid 47619399)
4. Peeters PH, Slimani N, van der Schouw YT, et al. (2007) Variations in plasma phytoestrogen concentrations in European adults. J Nutr 137, 1294-1300. (Pubitemid 46701925)
5. Mazur W (1998) Phytoestrogen content in foods. Baillière's Clin Endocrinol Metab 12, 729-742. (Pubitemid 29261280)
6. Adlercreutz H, Mousavi Y, Clark J, et al. (1992) Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 41, 331-337.
7. Zeleniuch-Jacquotte A, Lundin E, Micheli A, et al. (2006) Circulating enterolactone and risk of endometrial cancer. Int J Cancer 119, 2376-2381. (Pubitemid 44546959)
8. Horn-Ross PL, John EM, Canchola AJ, et al. (2003) Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 95, 1158-1164. (Pubitemid 37045394)
9. Bandera E, Williams M, Sima C, et al. (2009) Phytoestrogen consumption and endometrial cancer risk: a populationbased case-control study in New Jersey. Cancer Causes Control 20, 1117-1127.
10. Tjonneland A, Olsen A, Boll K, et al. (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35, 432-441. (Pubitemid 47386794)
11. Tjonneland A, Overvad K, Haraldsdottir J, et al. (1991) Validation of a semiquantitative food frequency questionnaire developed in Denmark. Int J Epidemiol 20, 906-912.
12. Adlercreutz H, Wang GJ, Lapc?́k O, et al. (1998) Timeresolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 265, 208-215.
13. Stumpf K, Uehara M, Nurmi T, et al. (2000) Changes in the time-resolved fluoroimmunoassay of plasma enterolactone. Anal Biochem 284, 153-157.
14. Prentice RL (1986) A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73, 1-11.
15. Barlow WE, Ichikawa L, Rosner D, et al. (1999) Analysis of case-cohort designs. J Clin Epidemiol 52, 1165-1172. (Pubitemid 29535416)
16. Greenland S (1995) Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology 6, 450-454.
17. Greenland S (1995) Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6, 356-365.
18. Kilkkinen A, Pietinen P, Klaukka T, et al. (2002) Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 155, 472-477. (Pubitemid 34174159)
19. Storm HH, Michelsen EV, Clemmensen IH, et al. (1997) The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 44, 535-539.
20. Milder IE, Kuijsten A, Arts IC, et al. (2007) Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population. J Nutr 137, 1266-1271. (Pubitemid 46701921)
21. Adlercreutz H (2002) Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 83, 113-118. (Pubitemid 37040647)
22. Kuijsten A, Arts IC, Vree TB, et al. (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135, 795-801. (Pubitemid 40464107)
23. Hausner H, Johnsen NF, Hallund J, et al. (2004) A single measurement is inadequate to estimate enterolactone levels in Danish postmenopausal women due to large intraindividual variation. J Nutr 134, 1197-1200. (Pubitemid 38619962)
24. Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A, et al. (1998) Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Cancer Epidemiol Biomarkers Prev 7, 885-889. (Pubitemid 28471576)
25. Lampe JW (2003) Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133, Suppl. 3, 956-964.